Paradoxical reaction to treatment in 2 patients with severe acute paracoccidioidomycosis: A previously unreported complication and its management with corticosteroids

Clinical Infectious Diseases

Volumn 50, Issue 10, 2010, Pages

  Gryschek, Ronaldo C B ^a   Pereira, Ricardo M ^f   Kono, Adriana ^a   Patzina, Rosely A ^b   Tresoldi, Antonia T ^f   Shikanai Yasuda, Maria A ^a,c   Benard, Gil ^d,e  

^a Clinical Hospital   (Brazil)

^b Department of Pathology ^*  (Brazil)

^c Laboratory of Medical Investigation Unit 48   (Brazil)

^d Laboratory of Medical Investigation Unit 56   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; COTRIMOXAZOLE; ITRACONAZOLE; PREDNISONE; SULFADIAZINE;

ACUTE DISEASE; ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG FEVER; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EOSINOPHILIA; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; NEPHROTOXICITY; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; SOUTH AMERICAN BLASTOMYCOSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTIFUNGAL AGENTS; CHILD; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC FACTORS; LYMPH NODES; LYMPHOMATOID GRANULOMATOSIS; MALE; MICROSCOPY; NECK; PARACOCCIDIOIDOMYCOSIS; SKIN;

EID: 77951843542     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/652290     Document Type: Article

References (12)

1. Smith H. Paradoxical responses during chemotherapy of tuberculosis. J Infect 1987; 15: 1-3.
2. Ridley DS, Radia KB. The histological course of reactions in borderline leprosy and their outcome. Int J Lepr Other Mycobact Dis 1981; 49(4): 383-392.
3. French AM. Immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009; 48: 101-107.
4. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 2007; 7(6): 395-401. (Pubitemid 46765196)
5. Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis 2006; 42: 1639-1646.
6. Manabe YC, Campbell JD, Sydnor E, Moore RD. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007; 46: 456-462. (Pubitemid 350098697)
7. Benard G. An overview of the immunopathology of human paracoccidioidomycosis. Mycopathologia 2008; 165: 209-221.
8. Terra GMF, Rios-Gonçalves AJ, Londero AT, et al. Paracoccidioidomicose em crianças - apresentação de casos. ABP Supi Arquivos Brasileiros de Medicina 1991; 56: 8-15.
9. Carvalho SA, Cerri GG, Shiroma M, Shikanai-Yasuda MA, Barone AA, Amato Neto V. Inferior vena cava compression syndrome in paracoccidioidomycosis. Rev Inst Med Trop Sao Paulo 1986; 28: 61-64.
10. Shikanai-Yasuda MA, Higaki Y, Uip DE, et al. Bone marrow involvement and eosinophilia in paracoccidioidomycosis. Rev Inst Med Trop Sao Paulo 1992; 34: 85-90.
11. Marais S, Wilkinson RJ, Pepper DJ, Meintjcs G. Management of patients with the immune reconstitution inflammatory syndrome. Curr HIV/AIDS Rep 2009; 6(3): 162-171.
12. Hawkey CR, Yap T, Pereira J, et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis 2005; 40: 1368-1371. (Pubitemid 40570251)